The quality-and-approval differences between compounded and FDA-approved branded medications are also real
21 Several incretin-based therapies, including liraglutide, dulaglutide, semaglutide, and tirzepatide, are currently approved for patients with type 2 diabetes ( Table )
Generally, individuals who are overweight or obese (with a body mass index or BMI of 27 or higher) may be eligible for Ozempic, especially if they have weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol
Research shows that two of the major catechins found in green tea, epicatechin gallate (ECG) and epigallocatechin gallate (EGCG), inhibit OATPs
This is where the pairing with Retatrutide becomes so relevant
There may be things you can do to mitigate some of these risks